Copyright © Inderes 2011 - present. All rights reserved.
Log in to receive notifications.
NoteHC Andersen Capital receives payment from Pharma Equity Group for a DigitalIR/Corporate Visibility agreement. See disclaimer.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Pharma Equity Group

0.08

 

DKK

 

-5.44 %

Less than 1K followers

PEG

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

-5.44%
-42.72%
-51.28%
-57.95%
-57.5%
-68.17%
-66.36%
-84.49%
-99.69%

Pharma Equity Group develops new medicines for the local treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The company uses repositioning of existing drugs and brings drug candidates to a clinical phase III stage, after which it is handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the company.

Read more
Market cap
98.08M DKK
Turnover
331.83K DKK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Coverage
Disclaimer
Claus Thestrup
Claus Thestrup

CEO, Sweden

Latest research

Latest analysis report

Released: 31.03.2025

Financial calendar
15.5
2025

Interim report Q1'25

14.8
2025

Interim report Q2'25

14.11
2025

Interim report Q3'25

All
Research
Webcasts
Press releases
3rd party
ShowingAll content types
Dagens aktienyheder 02/04: Gubra, Pharma Equity Group, Wirtek, ExpreS2ion Biotechnologies og Spar Nord Bank
Analyst Comment4/2/2025, 7:14 AM by
Claus Thestrup, Michael Friis, Rasmus Køjborg

Dagens aktienyheder 02/04: Gubra, Pharma Equity Group, Wirtek, ExpreS2ion Biotechnologies og Spar Nord Bank

Dagens aktienyheder med Gubra, Pharma Equity Group, Wirtek, ExpreS2ion Biotechnologies og Spar Nord Bank

GubraPharma Equity GroupWirtekExpreS2ion Biotech HoldingSpar Nord Bank
Pharma Equity Group: Udstedelse af konvertibelt lån
Analyst Comment4/1/2025, 2:27 PM by
Philip Coombes, Claus Thestrup

Pharma Equity Group: Udstedelse af konvertibelt lån

Pharma Equity Group: Udstedelse af konvertibelt lån

Pharma Equity Group
Regulatory press release4/1/2025, 11:29 AM

Bestyrelsens beslutning om udstedelse af konvertible lån

Pharma Equity Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/1/2025, 11:29 AM

The Board of Directors' resolution on the issuance of convertible loans

Pharma Equity Group
Dagens aktienyheder 01/04: Agillic, Audientes, Ascelia Pharma og Pharma Equity Group
Analyst Comment4/1/2025, 7:07 AM by
Claus Thestrup, Michael Friis, Rasmus Køjborg

Dagens aktienyheder 01/04: Agillic, Audientes, Ascelia Pharma og Pharma Equity Group

Dagens aktienyheder med Agillic, Audientes, Ascelia Pharma og Pharma Equity Group.

AgillicAudientesAscelia PharmaPharma Equity Group
Pharma Equity Group (One-pager): Proof-of-Concept year 2025
Research3/31/2025, 2:16 PM by
Philip Coombes, Claus Thestrup

Pharma Equity Group (One-pager): Proof-of-Concept year 2025

Pharma Equity Group (One-pager): Proof-of-Concept year 2025

Pharma Equity Group
Regulatory press release3/25/2025, 10:00 AM

Indkaldelse til ordinær generalforsamling i Pharma Equity Group A/S

Pharma Equity Group
Regulatory press release3/25/2025, 10:00 AM

Notice convening the annual general meeting in Pharma Equity Group A/S

Pharma Equity Group
Dagens aktienyheder 21.03.2025: Bioporto, Pharma Equity Group, Flügger Group og Windowmaster
Analyst Comment3/21/2025, 7:54 AM by
Rasmus Køjborg, Claus Thestrup

Dagens aktienyheder 21.03.2025: Bioporto, Pharma Equity Group, Flügger Group og Windowmaster

Dagens aktienyheder 21.03.2025: Bioporto, Pharma Equity Group, Flügger Group og Windowmaster

BioPortoPharma Equity GroupFlügger GroupWindowMaster International
Pharma Equity Group: Wrap up fra interview med CEO Thomas K. Selsø
Analyst Comment3/21/2025, 7:00 AM by
Claus Thestrup

Pharma Equity Group: Wrap up fra interview med CEO Thomas K. Selsø

Pharma Equity Group: Wrap up fra interview med CEO Thomas K. Selsø

Pharma Equity Group
Pharma Equity Group – Opdatering på helåret 2024
Webcast3/20/2025, 12:00 PM

Pharma Equity Group – Opdatering på helåret 2024

Mød og stil spørgsmål til CEO Thomas K. Selsø fra Pharma Equity Group torsdag den 20. marts 2025 kl 13:00. Fokus for dette event vil årsregnskabet for 2024, samt pipeline opdatering på RNX-011(Perionitis) og RNX-051(tyktarmscancer). Derudover vil CEO Thomas K. Selsø give en opdatering på drøftelserne med potentielle partnere.

Pharma Equity Group
Dagens aktienyheder 20/03: Bioporto, Pharma Equity Group, NTG, GreenMobility, WindowMaster, Flügger og SaaS nyhedsbrev.
Analyst Comment3/20/2025, 8:16 AM by
Claus Thestrup, Kasper Lihn, Rasmus Køjborg

Dagens aktienyheder 20/03: Bioporto, Pharma Equity Group, NTG, GreenMobility, WindowMaster, Flügger og SaaS nyhedsbrev.

Dagens aktienyheder med Bioporto, Pharma Equity Group, WindowMaster, NTG, GreenMobility, Flügger og SaaS nyhedsbrev.

BioPortoPharma Equity GroupWindowMaster InternationalNTG Nordic Transport GroupGreenMobilityFlügger Group
Pharma Equity Group: Helårsregnskab 2024 samt guidance 2025
Analyst Comment3/20/2025, 7:54 AM by
Claus Thestrup

Pharma Equity Group: Helårsregnskab 2024 samt guidance 2025

Pharma Equity Group: Helårsregnskab 2024 samt guidance 2025

Pharma Equity Group
Regulatory press release3/20/2025, 7:03 AM

Pharma Equity Group A/S - Annual Report 2024

Pharma Equity Group
Regulatory press release3/20/2025, 7:03 AM

Pharma Equity Group A/S - Årsrapport 2024

Pharma Equity Group
Dagens aktienyheder 03/03: GrønlandsBANKEN, Gubra og Pharma Equity Group A/S (PEG)
Analyst Comment3/3/2025, 8:00 AM

Dagens aktienyheder 03/03: GrønlandsBANKEN, Gubra og Pharma Equity Group A/S (PEG)

Dagens aktienyheder med GrønlandsBANKEN, Gubra og Pharma Equity Group A/S (PEG)

GrønlandsbankenGubraPharma Equity Group
Pharma Equity Group: Vagtskifte og organisationsændring
Analyst Comment3/3/2025, 7:13 AM by
Claus Thestrup, Philip Coombes

Pharma Equity Group: Vagtskifte og organisationsændring

Pharma Equity Group: Vagtskifte og organisationsændring

Pharma Equity Group
Press release2/28/2025, 12:19 PM

2025 Financial Calendar

Pharma Equity Group
Press release2/28/2025, 12:19 PM

2025 Finanskalender

Pharma Equity Group
Regulatory press release2/28/2025, 11:56 AM

Change of executive management and organizational change in Pharma Equity Group A/S

Pharma Equity Group
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.